Hisao Sasai et al.Download PDFPatent Trials and Appeals BoardNov 29, 201915233069 - (D) (P.T.A.B. Nov. 29, 2019) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/233,069 08/10/2016 Hisao SASAI 2016-1018 9963 513 7590 11/29/2019 WENDEROTH, LIND & PONACK, L.L.P. 1025 Connecticut Avenue, NW Suite 500 Washington, DC 20036 EXAMINER MUNG, ON S ART UNIT PAPER NUMBER 2486 NOTIFICATION DATE DELIVERY MODE 11/29/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): eoa@wenderoth.com kmiller@wenderoth.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte HISAO SASAI, TAKAHIRO NISHI, YOUJI SHIBAHARA, TOSHIYASU SUGIO, and VIRGINIE DRUGEON Appeal 2018-008590 Application 15/233,069 Technology Center 2400 BEFORE JOSEPH L. DIXON, JAMES R. HUGHES, and ERIC S. FRAHM, Administrative Patent Judges. DIXON, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Pursuant to 35 U.S.C. § 134(a), Appellant,1 Sun Patent Trust, appeals from the Examiner’s decision to reject claims 6–8. (Final Act. 1.) We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 We use the word “Appellant” to refer to “Applicant” as defined in 37 C.F.R. § 1.42(a). Appellant identifies the real party in interest as Sun Patent Trust. (Appeal Br. 1.) Appeal 2018-008590 Application 15/233,069 2 CLAIMED SUBJECT MATTER The claims are directed to an image decoding method and image decoding apparatus. Claim 6, reproduced below, is illustrative of the claimed subject matter: 6. An decoding method for decoding an image on a block- by-block basis, the decoding method comprising: decoding mode information that specifies one selected prediction mode, the one selected prediction mode being selected from among a plurality of prediction modes including a plurality of direction prediction modes and two predetermined prediction modes different from the plurality of direction prediction modes, the two predetermined prediction modes including a DC prediction mode; and decoding a current block to be decoded included in the image by predicting the current block using the selected one prediction mode, wherein the decoding mode information further includes: determining whether or not either one of the two predetermined prediction mode is selected as the one selected prediction mode; and when it is determined that both of the two predetermined prediction mode are not selected as the selected one prediction mode, determining one of the plurality of directional prediction modes as the one selected prediction mode, the plurality of directional prediction modes being different from the two predetermined prediction modes. (Appeal Br. 12, Claims Appendix.) REFERENCES The prior art relied upon by the Examiner is: Appeal 2018-008590 Application 15/233,069 3 Drugeon et al. US 2010/0128995 A1 May 27, 2010 Karczewicz et al. US 2012/0008683 A1 Jan. 12, 2012 REJECTIONS Claims 6–8 stand rejected under pre-AIA 35 U.S.C. § 112, first paragraph, as failing to comply with the written description requirement. Claims 6–8 stand rejected under pre-AIA 35 U.S.C. § 103(a) as being unpatentable over Karczewicz in view of Drugeon. OPINION Written Description Requirement To satisfy the written description requirement, the disclosure must reasonably convey to skilled artisans that Appellants possessed the claimed invention as of the filing date. Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. Cir. 2010) (en banc). With respect to the written description rejection of independent claims 6–8, Appellant argues the claims together. (Appeal Br. 5–6.) Therefore, we select independent claim 6 as the representative claim for the group and will address Appellant’s arguments thereto. 37 C.F.R. § 41.37(c)(1)(iv). With respect to representative independent claim 6, the Examiner maintains that the claim limitation ““when it is determined that both of the two predetermined predicting mode are not selected as the selected one prediction mode, determining one of the plurality of directional prediction modes as the one selected prediction mode”, is not disclosed in the Specification or figures and fails to comply with the written description requirement. (Final Act. 3; Ans. 7–8.) Appellant contends that paragraphs 74, 164, 184, and 240 support the claim limitations. (Appeal Br. 5–6; see also Appeal Br. 2–3.) Appellant Appeal 2018-008590 Application 15/233,069 4 further contends that when both of the two predetermined prediction modes are not selected as the one prediction mode, it necessarily follows that the selected one prediction mode must be one of the 33 directional prediction modes, and as such, it is respectfully submitted that one of ordinary skill in the art would reasonably understand the limitation is supported by the Specification as originally filed such that the Appellant was in possession of the invention as claimed. (Appeal Br. 5–6.) The Examiner further maintains that “the Examiner still could not find those limitations in the specification.” (Ans. 7.) We agree with the Examiner that the portions of the Specification identified by Appellant do not provide written description support to evidence possession at the time of the invention. Therefore, we sustain the rejection of representative independent claim 6 and independent claims 7 and 8 not separately argued. Obviousness With respect to the obviousness rejection of independent claims 6–8, Appellant argues the claims together. (Appeal Br. 6–8.) Therefore, we select independent claim 6 as the representative claim for the group and will address Appellant’s arguments thereto. 37 C.F.R. § 41.37(c)(1)(iv). Appellant argues that the Karczewicz and Drugeon references do not teach or suggest the claimed “decoding mode information” in the claimed decoding method. (Appeal Br. 6–9.) Appellant further contends that “paragraphs [0278]-[0280] and [0282] of Karczewicz determines whether or not DC prediction mode is signaled for the block, that is, Step 352 does not determine whether or not DC prediction mode is selected for the block.” (Appeal Br. 7–8.) Appellant does not identify any specific definition for the term “selected” in the Specification, and we note that the portions of the Appeal 2018-008590 Application 15/233,069 5 Specification identified in the Summary of the Claimed Subject Matter do not identify any specific definition for the term “selected.” Appellant addresses this specific teaching in isolation and does not address the Examiner’s further reliance upon the additional paragraphs 50– 52, 54, 105, and 158 of the Karczewicz reference as relied upon by the Examiner in the statement of the rejection. (See Final Act. 5–6.) Moreover, the Examiner further responds to the points argued by Appellant further addressing paragraphs 50 and 54 of the Karczewicz reference. (Ans. 8–9.) The Examiner further maintains that the “limitations disclosed by Karczewicz is equivalent to the claimed limitation “determining whether or not either one of the two predetermined prediction mode is selected as the one selected prediction mode,” as claimed. (Ans. 9.) We agree with the Examiner that the signaling taught by the Karczewicz reference is equivalent and suggestive of the claimed “selected prediction mode.” The allocation of burdens requires that the USPTO produce the factual basis for its rejection of an application under 35 U.S.C. §§ 102 and 103. In re Piasecki, 745 F.2d 1468, 1472 (Fed. Cir. 1984) (citing In re Warner, 379 F.2d 1011, 1016 (CCPA 1967)). The one who bears the initial burden of presenting a prima facie case of unpatentability is the Examiner. In re Oetiker, 977 F.2d 1443, 1445 (Fed. Cir. 1992). A prima facie case is established when the party with the burden of proof points to evidence that is sufficient, if uncontroverted, to entitle it to prevail as a matter of law. See Saab Cars USA, Inc. v. U. S., 434 F.3d 1359, 1369 (Fed. Cir. 2006). In particular, regarding the Patent Examiner’s burden of production: [A]ll that is required of the office to meet its prima facie burden of production is to set forth the statutory basis of the rejection Appeal 2018-008590 Application 15/233,069 6 and the reference or references relied upon in a sufficiently articulate and informative manner as to meet the notice requirement of [35 U.S.C.] § 132. As the statute itself instructs, the examiner must “notify the applicant,” “stating the reasons for such rejection,” “together with such information and references as may be useful in judging the propriety of continuing prosecution of his application.” 35 U.S.C. § 132. In re Jung, 637 F.3d 1356, 1363 (Fed. Cir. 2011). Therefore, we find Appellant’s argument to be unavailing because we agree with the Examiner that the signaling of the prediction would be decoded as a selection of a prediction mode. Appellant did not file a Reply Brief to respond to the Examiner’s additional factual findings and discussion of the additional portions of the Karczewicz reference relied upon by the Examiner in the grounds of the rejection. Consequently, Appellant’s argument does not show error in the Examiner’s factual findings or conclusion of obviousness of representative independent claim 6. With respect to independent claims 7 and 8, Appellant relies upon the arguments advanced with respect to independent claim 6. (Appeal Br. 9.) Therefore, independent claims 7 and 8 fall with representative independent claim 6. DECISION The Examiner’s written description and obviousness rejections are affirmed. Appeal 2018-008590 Application 15/233,069 7 DECISION SUMMARY Claims Rejected 35 U.S.C. § Basis Affirmed Reversed 6–8 112, para. 1 Written description 6–8 6–8 103 Karczewicz, Drugeon 6–8 Overall outcome 6–8 FINALITY AND RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation